Thu, February 4, 2021
Wed, February 3, 2021
Tue, February 2, 2021
Mon, February 1, 2021
Sun, January 31, 2021
Fri, January 29, 2021
Thu, January 28, 2021
Wed, January 27, 2021

Ken Cacciatore Maintained (ARQT) at Buy with Increased Target to $80 on, Feb 1st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-80-on-feb-1st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ken Cacciatore of Cowen & Co., Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $55 to $80 on, Feb 1st, 2021.

Ken has made no other calls on ARQT in the last 4 months.



There are 2 other peers that have a rating on ARQT. Out of the 2 peers that are also analyzing ARQT, 0 agree with Ken's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ken


  • Graig Suvannavejh of "Goldman Sachs" Upgraded from Hold to Strong Buy and Held Target at $36 on, Monday, November 9th, 2020
  • Gregg Gilbert of "Truist Securities" Initiated at Strong Buy and Held Target at $38 on, Thursday, October 8th, 2020

Publication Contributing Sources